Researchers from the US have shown that combination therapy with sitagliptin and metformin results in a substantial and additive glycemic improvement in patients with type 2 diabetes. Sitagliptin ...

[31] Double-blind, placebo-controlled studies on the safety and efficacy of sitagliptin have been conducted with patients with Type 2 diabetes. Mean age was 55 and participants were of varying ...

2008 Future Drugs Ltd. Cite this: Initial Combination Therapy With Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, and Metformin for Patients With Type 2 Diabetes Mellitus - Medscape - Jan 01 ...

Sitagliptin, metformin (as HCl) ext-rel; 50mg/500mg, 50mg/1000mg, 100mg/1000mg; tabs. Individualize. Swallow whole. Take once daily with a meal, preferably in the evening. Not currently treated ...

type 1 diabetes, and hypersensitivity. Adult- PO- For Native Patients- The recommended starting dose is metformin 50 mg & sitagliptin/500 mg twice daily. The starting dose in patients already ...

Merck described Januvia as “an important advance for adults with type 2 diabetes” and added that innovations like sitagliptin ...

8,414,921), which covers the co-formulation of sitagliptin and metformin and is ... strong despite increasing pressure in the type 2 diabetes market and price pressures, particularly in ...